The Patient Capital Review is two months late and as a result, warns Tom Hopkins, there is a danger some decisions could be rushed through in time for the Autumn Statement and based on out-of-date statistics
Since the Brexit vote, the hugely influential European Investment Fund (EIF) has begun turning off the taps. For its part, the UK government has released the Patient Capital Review in an attempt to review how the UK is supporting growth businesses or, to use the new buzzword, ‘scale-ups' both now and in the future. There are essentially three key questions, here: * Is there an equity gap for entrepreneurial businesses? * If so, where is it? * How can the UK government plug it - especially given the EIF situation? The EIF is a European Union agency, effectively funded by membe...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes